Data collection:
The inclusion criteries were;- Patients older than 18 years of age with moderate / severe pneumonia hospitalized in our hospital with the diagnosis of COVID-19 confirmed by PCR on nasopharyngeal swab, - Given high-dose steroid therapy in clinical follow-up, (>250 mg/day methylprednisolone, 3 days) - Patients whose blood tests, X-ray images, and thoracic computed tomography sections were accessible - Patients with full access to the researched criteria on file or computer. Patients whose criteria could not be reached on file or computer were excluded from the study.
The reviewed and noted variables included patients’ demographic characteristics, co-morbidities existing prior to the admission, time of illness onset and hospital admission, radiology findings, laboratory test results, medications and supportive care, further medical applications, and clinical outcomes. Data on the type, maximum daily dose, first started time, and duration of corticosteroids were collected.